Blood test can detect rejection of transplanted kidney

03/16/2012 | MedCityNews.com

A new molecular blood test uses RNA genetic markers to detect signs of renal failure following a kidney transplant. The test, which can identify kidney failure weeks before clinical symptoms manifest, can serve as a safer alternative to a renal biopsy, which can lead to graft injury or loss or bleeding, according to Quest Diagnostics.

View Full Article in:

MedCityNews.com

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
President/Chief Executive Officer
MedCost
Winston-Salem, NC
Consumer Directed Health Plan (CDH) Product Offering Manager
Blue Cross Blue Shield MA
Quincy, MA
Director, Payer Marketing
Avalere Health
Washington, DC
Actuary
Meridian Health Plan
Detroit, MI
Chief Medical Officer, Texas Children's Health Plan
Cejka Executive Search for Texas Childre's Health Plan
Houston, TX